乳腺癌的最新见解:分子途径,表观遗传调节和新兴的向疗法
Quratulain Maqsood1,2, Muhammad Umer Khan3, Tehreem Fatima2
1Department of Food Science, Institute of Agricultural Sciences, University of the Punjab, Lahore, Pakistan.
Breast cancer : basic and clinical research
|July 15, 2025
概括
本综述探讨了推动乳腺癌发展和耐药性的分子和表观遗传因素. 了解这些机制,包括关键途径和表观遗传点,对于开发个性化疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 乳腺癌是妇女死亡的主要原因,不同的分子亚型影响治疗反应.
- 瘤的行为,转移和对治疗的抵抗受到不同的分子和表观遗传机制的影响.
- 关键的信号通路 (ER,HER2,Notch,FGFR,Wnt,Hedgehog) 在乳腺干细胞调节和瘤发生过程中至关重要.
研究的目的:
- 审查乳腺癌研究的最新进展,重点关注分子和表观遗传驱动因素.
- 突出表观遗传变化的作用 (DNA甲基化,基因素修饰,微RNAs) 在瘤开始和治疗耐药性.
- 讨论针对个性化乳腺癌治疗的新型治疗策略和生物标志物.
主要方法:
- 关于乳腺癌分子和表观遗传机制的最新研究的文献综述.
- 对参与瘤发生和干细胞调节的关键信号通路的分析.
- 检查表观遗传点 (DNMT,HDAC,EZH2,非编码RNA) 和它们的治疗潜力.
主要成果:
- 表观遗传变化显著调节基因活性,有助于瘤启动和治疗抵抗.
- 正在出现表观遗传标和生物标志物,以改善诊断,预后和风险评估.
- 像CAR-T细胞疗法和纳米颗粒药物输送等新型疗法对精准医学有很大的前景.
结论:
- 对乳腺癌的分子和表观遗传环境的全面了解对于有效治疗至关重要.
- 多基因测试和表观遗传生物标记物的整合使得个性化治疗策略成为可能.
- 新兴的治疗方法为乳腺癌护理中的精准医学提供了新的途径.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.1K
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K